Connect Biopharma Holdings's top three insider shareholders as of April 17, 2026 are James Huang (Director, 13.16Mn shares), Kleanthis Gabriel Xanthopoulos (Director, 82.82K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| James Huang | - | 0 | 13,160,000 | 01 Apr, 2026 |
| Kleanthis Gabriel Xanthopoulos | - | 82,816 | 0 | 02 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Mar, 2026 | Kleanthis Gabriel Xanthopoulos | Ordinary Shares | A | 2,816 | $0.00 | 82,816 | D | A |
| 31 Mar, 2026 | James Huang | Ordinary Shares | A | 1,160,000 | $3.45 | 13,160,000 | I | P |